Medication info
Albogen Cimetidine Tablet 400mg

Albogen Cimetidine Tablet 400mg

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›400mg / 1 tablet
Manufacturer / importer
Albogen Korea Co., Ltd.
Appearance
Pale blue oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200302205 · Notified 2003.09.05 · Insurance code 652603720

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease) and improvement of gastritis-related gastric mucosal lesions
Who takes it
Adults · Children
Adult dose
Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased for some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis, resume administration according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Albogen Korea Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease) and improvement of gastritis-related gastric mucosal lesions

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomosis ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is effective for various gastrointestinal disorders such as ulcers in the stomach and duodenum, gastroesophageal reflux disease, recurrent ulcers, anastomosis ulcers, and Zollinger-Ellison syndrome. It is also used to improve gastric mucosal lesions, like erosions, bleeding, redness, and swelling, occurring in acute exacerbations of acute gastritis and chronic gastritis. This medication helps protect the gastric mucosa and alleviate inflammation, thereby improving symptoms. It is effective in reducing discomfort caused by gastrointestinal disorders and improving digestive health.

How to take

Adult dose

Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased for some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis, resume administration according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

Care must be taken when cutting a glass ampule if this medication is in injectable form. If glass fragments mix in, adverse reactions can occur, especially when used by children or the elderly. People who have hypersensitivity to this medication or are allergic to any of its components should not take it. Patients taking certain medications that carry the risk of specific cardiac arrhythmias should also avoid using it. Patients with lactose intolerance or certain genetic metabolic disorders should also refrain from using this medication. Patients with impaired kidney or liver function may experience increased concentration of this medication, so dosages should be adjusted or intervals extended with caution. Elderly patients, children, and patients undergoing hemodialysis should also take this medication cautiously, and conditions indicating gastric cancer should be confirmed before use as symptoms may be obscured. Patients who test positive for Helicobacter pylori should also undergo eradication treatment. While taking this medication, various side effects such as leukopenia, liver function abnormalities, kidney issues, allergic reactions, gynecomastia, digestive disorders, neuropsychiatric symptoms, cardiac arrhythmias, and severe skin reactions might occur. If any abnormal symptoms appear, discontinue the medication immediately and consult your doctor. The medication should be administered in the minimal effective dosage, and if it is not effective, other treatments should be considered. Regular monitoring of conditions is particularly important for elderly patients and those with a history of peptic ulcers. Interaction with other medications may occur when taken together, so it should only be taken after consulting a physician. The safety of this medication has not been established for pregnant or breastfeeding women, and it should only be used when absolutely necessary; breastfeeding should be suspended during treatment. Caution should be exercised when administering it to children, and elderly patients may need dosage adjustments due to impaired kidney function. In cases of overdose, there is a risk of respiratory depression, and immediate medical treatment should be sought. When used as an injectable, it should be administered slowly to reduce the risk of side effects. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container. Some reports suggest that it may affect certain reproductive organs in animal studies, although it is known not to have significant effects on reproductive capability in clinical settings.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
Show 47 more
  • elevated ALT
  • liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactic-like reactions
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased vaginal discharge
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb numbness
  • rigidity
  • drowsiness
  • hypochondriacal symptoms
  • weakness
  • altered consciousness
  • confusion
  • sinus bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema edema
  • fatigue
  • fever
  • systemic warmth
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture ingress, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Pale blue oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.